AUG 01, 2019 12:57 PM PDT

How cancer tricks our immune systems

Research published yesterday in Nature details the finding of a new “Don’t eat me” signal that cancers use to hide from the body’s immune system. Previous proteins with a similar role have been identified in past studies, but the discovery of this new protein, called CD24, may lead the way to novel anti-cancer therapies. The study comes from researchers at the Stanford University School of Medicine.

CD24 is one of several other proteins including PD-L1, CD47 and the beta-2-microglobulin subunit of the major histocompatibility class 1 complex that allow cancer cells to essentially evade immune cells called macrophages that are tasked with destroying unwanted pathogens. Based on that previous research, several cancer treatments that block or target the previously found proteins are already in clinical trials.

Senior author Irving Weissman, MD, professor of pathology and of developmental biology and director of the Stanford Institute for Stem Cell Biology and Regenerative Medicine explained that "Finding that not all patients responded to anti-CD47 antibodies helped fuel our research at Stanford to test whether non-responder cells and patients might have alternative 'don't eat me' signals.”

In the study, the researchers discovered that many cancers produce an abundance of CD24 compared with normal cells and surrounding tissues. They were clued in to look for the proteins because of the implication it has. Lead author Amira Barkal explains: "You know that if cancers are growing in the presence of macrophages, they must be making some signal that keeps those cells from attacking the cancer. You want to find those signals so you can disrupt them and unleash the full potential of the immune system to fight the cancer."

Photo: Pixabay

To test their findings, the research team implanted human breast cancer cells in mice and determined that blocking CD24 signaling in the cancer cells resulted in the mice’s immune system macrophages attacking the cancer cells. "When we imaged the macrophages after treating the cancers with CD24 blockade, we could see that some of them were just stuffed with cancer cells," Barkal said.

The team hopes to continue investigating these signals with the hope that their findings will evolve into even more available anti-cancer therapies. "There are probably many major and minor 'don't eat me' signals, and CD24 seems to be one of the major ones," Barkal said. The findings may have particular impact on ovarian and triple-negative breast cancer, both of which responded well to blocking CD24. “This may be a vulnerability for those very dangerous cancers," added Barkal.

Sources: Science Daily, Nature

About the Author
BA Environmental Studies
Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
SEP 05, 2022
Cancer
A Look at Occupational Cancers on Labor Day
SEP 05, 2022
A Look at Occupational Cancers on Labor Day
Today marks Labor Day in the United States, an annual celebration of the American workforce and its contribution to the ...
SEP 25, 2022
Genetics & Genomics
The next generation of library preparation solutions for DNA sequencing
SEP 25, 2022
The next generation of library preparation solutions for DNA sequencing
The next generation of library preparation solutions for DNA sequencing  Since the completion of the Human Genome P ...
OCT 04, 2022
Cardiology
Brisk Walking Reduces Risk of Heart Disease, Cancer, and More
OCT 04, 2022
Brisk Walking Reduces Risk of Heart Disease, Cancer, and More
Getting your steps in at a brisker pace reduces the risk of cancer, heart disease, dementia, and premature death.
OCT 06, 2022
Cancer
Caregivers Need Exercise Too
OCT 06, 2022
Caregivers Need Exercise Too
We all know that exercise and a good diet benefit overall health.  Several studies indicate that cancer survivorshi ...
DEC 02, 2022
Genetics & Genomics
Tips on Establishing a Reliable Cell Free DNA Workflow
DEC 02, 2022
Tips on Establishing a Reliable Cell Free DNA Workflow
Ever since its first discovery in 1948, circulating cell-free DNA (cfDNA) has captured the attention and imagination of ...
NOV 29, 2022
Cancer
Some Pediatric Cancer Survivors Experience Premature Aging
NOV 29, 2022
Some Pediatric Cancer Survivors Experience Premature Aging
Aging occurs when molecular damage accumulates in cells and tissues throughout the body resulting in dysfunction and dys ...
Loading Comments...